Form 4: Zentalis Pharmaceuticals Executive Cam Gallagher Sells Shares to Cover Tax Obligations

Cam Gallagher, President and Interim CFO of Zentalis Pharmaceuticals, sold 9,597 shares of common stock on May 31, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 31, 2024, Cam Gallagher, President and Interim CFO of Zentalis Pharmaceuticals, sold 9,597 shares of common stock.
• The sale was executed at a price of $11.98 per share.
• The transaction was conducted automatically by the Issuer to cover tax withholding obligations associated with the vesting and settlement of previously granted restricted stock units.
• Following the transaction, Gallagher directly owns 633,680 shares of Zentalis Pharmaceuticals.
• The sale was effected pursuant to a Rule 10b5-1 trading arrangement.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) and doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. The use of a 10b5-1 trading plan is also a common practice to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the explanation provided (tax obligations, 10b5-1 plan) mitigates this concern.

Key Dates